TScan Therapeutics
TCRX
#9293
Rank
$67.9 M
Marketcap
$1.20
Share price
-4.76%
Change (1 day)
-83.65%
Change (1 year)

TScan Therapeutics (TCRX) - Cash on Hand

Cash on Hand as of December 2024 : $0.29 Billion USD

According to TScan Therapeutics's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

TScan Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.29 B51.06%
2023-12-31$0.19 B60%
2022-12-31$0.12 B-25.64%
2021-12-31$0.16 B363.93%
2020-12-31$34.79 M-16.7%
2019-12-31$41.76 M